181 related articles for article (PubMed ID: 30963446)
1. Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions.
Tonin FS; Lopes LA; Rotta I; Bonetti AF; Pontarolo R; Correr CJ; Fernandez-Llimos F
Int J Clin Pharm; 2019 Jun; 41(3):785-792. PubMed ID: 30963446
[TBL] [Abstract][Full Text] [Related]
2. Inter-review agreement of risk-of-bias judgments varied in Cochrane reviews.
Könsgen N; Barcot O; Heß S; Puljak L; Goossen K; Rombey T; Pieper D
J Clin Epidemiol; 2020 Apr; 120():25-32. PubMed ID: 31866473
[TBL] [Abstract][Full Text] [Related]
3. Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.
Barcot O; Boric M; Poklepovic Pericic T; Cavar M; Dosenovic S; Vuka I; Puljak L
BMC Med Res Methodol; 2019 Aug; 19(1):170. PubMed ID: 31382898
[TBL] [Abstract][Full Text] [Related]
4. The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey.
Babic A; Pijuk A; Brázdilová L; Georgieva Y; Raposo Pereira MA; Poklepovic Pericic T; Puljak L
BMC Med Res Methodol; 2019 Apr; 19(1):77. PubMed ID: 30971219
[TBL] [Abstract][Full Text] [Related]
5. Adequacy of risk of bias assessment in surgical vs non-surgical trials in Cochrane reviews: a methodological study.
Barcot O; Boric M; Dosenovic S; Cavar M; Jelicic Kadic A; Poklepovic Pericic T; Vukicevic I; Vuka I; Puljak L
BMC Med Res Methodol; 2020 Sep; 20(1):240. PubMed ID: 32993499
[TBL] [Abstract][Full Text] [Related]
6. The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application.
Minozzi S; Cinquini M; Gianola S; Gonzalez-Lorenzo M; Banzi R
J Clin Epidemiol; 2020 Oct; 126():37-44. PubMed ID: 32562833
[TBL] [Abstract][Full Text] [Related]
7. Risk of bias assessments and reporting quality of systematic reviews and randomized controlled trials examining acupuncture for depression: An overview and meta-epidemiology study.
Luo S; Long Y; Xiao W; Wang X; Chen R; Guo Q; Liu J; Shao R; Du L; Chen M
J Evid Based Med; 2020 Feb; 13(1):25-33. PubMed ID: 32112515
[TBL] [Abstract][Full Text] [Related]
8. Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains.
Barcot O; Boric M; Dosenovic S; Puljak L
BMC Med Res Methodol; 2021 Jul; 21(1):149. PubMed ID: 34275437
[TBL] [Abstract][Full Text] [Related]
9. Risk of bias and magnitude of effect in orthodontic randomized controlled trials: a meta-epidemiological review.
Koletsi D; Spineli LM; Lempesi E; Pandis N
Eur J Orthod; 2016 Jun; 38(3):308-12. PubMed ID: 26174770
[TBL] [Abstract][Full Text] [Related]
10. SYRCLE's risk of bias tool for animal studies.
Hooijmans CR; Rovers MM; de Vries RB; Leenaars M; Ritskes-Hoitinga M; Langendam MW
BMC Med Res Methodol; 2014 Mar; 14():43. PubMed ID: 24667063
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Risk of Bias of a Study.
Faggion CM
J Evid Based Dent Pract; 2015 Dec; 15(4):164-70. PubMed ID: 26698002
[TBL] [Abstract][Full Text] [Related]
12. Quality Assessment of Randomized Controlled Trials of Moxibustion Using STandards for Reporting Interventions in Clinical Trials of Moxibustion (STRICTOM) and Risk of Bias (ROB).
Kim SY; Lee EJ; Jeon JH; Kim JH; Jung IC; Kim YI
J Acupunct Meridian Stud; 2017 Aug; 10(4):261-275. PubMed ID: 28889843
[TBL] [Abstract][Full Text] [Related]
13. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
Bilandzic A; Fitzpatrick T; Rosella L; Henry D
PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153
[TBL] [Abstract][Full Text] [Related]
14. Risk of bias of randomized trials over time.
Reveiz L; Chapman E; Asial S; Munoz S; Bonfill X; Alonso-Coello P
J Clin Epidemiol; 2015 Sep; 68(9):1036-45. PubMed ID: 26227423
[TBL] [Abstract][Full Text] [Related]
15. Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews.
Yao Y; Shen J; Luo J; Li N; Liao X; Zhang Y
Trials; 2024 Jun; 25(1):405. PubMed ID: 38907276
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation.
Savović J; Weeks L; Sterne JA; Turner L; Altman DG; Moher D; Higgins JP
Syst Rev; 2014 Apr; 3():37. PubMed ID: 24731537
[TBL] [Abstract][Full Text] [Related]
17. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
[TBL] [Abstract][Full Text] [Related]
18. Assessment of risk of bias in quasi-randomized controlled trials and randomized controlled trials reported in the
Kim JH; Kim TK; In J; Lee DK; Lee S; Kang H
Korean J Anesthesiol; 2017 Oct; 70(5):511-519. PubMed ID: 29046770
[TBL] [Abstract][Full Text] [Related]
19. Overall bias and sample sizes were unchanged in ICU trials over time: a meta-epidemiological study.
Anthon CT; Granholm A; Perner A; Laake JH; Møller MH
J Clin Epidemiol; 2019 Sep; 113():189-199. PubMed ID: 31150836
[TBL] [Abstract][Full Text] [Related]
20. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project.
Correr CJ; Melchiors AC; de Souza TT; Rotta I; Salgado TM; Fernandez-Llimos F
Ann Pharmacother; 2013; 47(7-8):946-52. PubMed ID: 23757389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
